PAK1 and pancreatic adenocarcinoma: Moreover, Inhibition of PAK1 by shRNA or pharmacology inhibitor IPA-3 also attenuates cell migration in vitro and tumor metastasis in a model of pancreatic adenocarcinoma [18].